ICHS Awards
The International Immunocompromised Host Society 2018 Awards
New For Our Society - First Ever Awards!
New for our Society, the International Immunocompromised Host Society has awarded, for the first time, a Lifetime Achievement award, a Young Investigator award and the ICHS Society Citation award to three highly qualified ICHS members. The awards were presented during the closing ceremony of the 20th ICHS Symposium on Tuesday, 19 June, 2018. Congratulations to the recipients!
The International Immunocompromised Host Society Lifetime Achievement AwardDr. Thomas J Walsh, Recipient of the First ICHS Lifetime Achievement Award
Widely recognized as one of the world’s preeminent mycologists, his internationally recognized translational research of invasive mycoses in immunocompromised hosts has revolutionized the field, his teaching and mentoring have created a generation of new scholars, his devoted patient care has directly saved the lives of hundreds immunocompromised children and adults with severe invasive fungal infections worldwide, and his loyal service to ICHS has admirably strengthened its mission over three decades. Following graduation with honors from Johns Hopkins University School of Medicine, Dr. Walsh pursued a course of 10 years of post-doctoral training. He then worked for nearly a quarter-century at the National Cancer Institute, where he became Chief of the Immunocompromised Host Section in the Pediatric Oncology Branch. Read moreThe International Immunocompromised Host Society Young Investigator AwardDr. Michail Lionakis, recipient of the First ICHS Junior Investigator Award
At the lab of Dr. Kontoyiannis, Dr. Lionakis drove a variety of basic, translational and clinical research projects pertaining to the diagnosis, treatment and pathogenesis of opportunistic mycoses in humans and in mouse and Drosophila models of fungal disease. He then did his Internal Medicine Residency at Baylor College of Medicine (2004-2007) and his Infectious Diseases Fellowship in the National Institute of Allergy & Infectious Diseases (NIAID) of the National Institutes of Health (NIH). After that, he performed research training under the mentorship of Phil Murphy at NIAID, where he initiated basic immunological investigations on the role of chemoattractant receptors in host defense against invasive candidiasis in mice and humans. As recognition of his achievements as a physician-scientist at NIAID, he was elected Assistant Clinical Investigator in 2010 and Tenure-Track Investigator in 2012. The International Immunocompromised Host Society Citation AwardDr. Paul Quie, Recipient of the First ICHS Citation Award
From 1955-57, he served as a medical officer in the US Navy. In 1957. He returned to the UMN as a research fellow and as Chief Resident in Pediatrics. He served on the faculty of the Department of Pediatrics from 1958-1999 and was Chief of Staff at the University Hospitals from 1979-1984. From 1962-64, he was a guest investigator at the Rockefeller Institute in the laboratory of James G. Hirsch. He became the first director of the Biomedical Ethics Center in 1985. Dr. Quie headed the Division of Pediatric Infectious Diseases for many years and from 1998 through 2014, Co-Directed with Dr. Phillip Peterson, the International Medical Education and Research Program of the Medical School. He is currently Regents’ Professor Emeritus of Pediatrics and Distinguished International Professor. Dr Quie was both a founding member and the first president of ICHS. |
Dr. Thomas Walsh has dedicated his professional life to infectious diseases supportive care of children and adults with cancer, transplantation, and other immunodeficiencies. 
Dr Michail Lionakis was born in Chania, Greece on October 12, 1976. He received his MD from University of Crete, Greece in 2000 and relocated to the US to perform research training under the mentorship of Dimitrios Kontoyiannis at The University of Texas MD Anderson Cancer Center in 2002. 
Dr Paul Quie was born in Dennison, MN on February 3, 1925. He received his BA from St. Olaf College in 1949 and his MD from Yale Medical School in 1953. He did his internship at Minneapolis General Hospital (1953-54) and his residency in Pediatrics at the University of Minnesota University Hospitals (1954).
| International Immunocompromised Host SocietyICHS Executive Director | Beth Kassalen | admin@ichs.org |